Plasma antioxidants in pediatric patients with glycogen storage disease, diabetes mellitus, and hypercholesterolemia
- 19 June 2002
- journal article
- Published by Elsevier in Free Radical Biology & Medicine
- Vol. 33 (1) , 103-110
- https://doi.org/10.1016/s0891-5849(02)00863-8
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Cell-mediated immunity in atherosclerosisCurrent Opinion in Lipidology, 1997
- Antioxidants and Atherosclerotic Heart DiseaseNew England Journal of Medicine, 1997
- α-Tocopherol Inhibits Aggregation of Human Platelets by a Protein Kinase C–Dependent MechanismCirculation, 1996
- The effects of alpha tocopherol supplementation on monocyte function. Decreased lipid oxidation, interleukin 1 beta secretion, and monocyte adhesion to endothelium.Journal of Clinical Investigation, 1996
- Vascular incorporation of alpha-tocopherol prevents endothelial dysfunction due to oxidized LDL by inhibiting protein kinase C stimulation.Journal of Clinical Investigation, 1996
- Impairment of Endothelium-Dependent Dilation in Rabbit Renal Arteries by Oxidized Lipoprotein(a)Circulation, 1995
- Glucose-6-phosphate: A key compound in glycogenosis I and favism leading to hyper- or hypolipidaemiaEuropean Journal of Pediatrics, 1993
- Lysophosphatidylcholine inhibits surface receptor-mediated intracellular signals in endothelial cells by a pathway involving protein kinase C activation.Circulation Research, 1992
- Autoantibody against oxidised LDL and progression of carotid atherosclerosisThe Lancet, 1992
- Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic ComplicationsNew England Journal of Medicine, 1988